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Summary 
Francisella tularensis is a gram-negative facultative intracellular 
bacterial pathogen that in humans and animals causes the fulminating 
zoonotic disease tularemia. Free-living amoeba, such as A. castellanii and 
D. discoideum, serve as environmental hosts of various intracellular 
pathogens. Epidemiology of F. tularensis is commonly associated with 
water-borne transmission in some parts of the world, including mosquitoes 
and amoebae as the host reservoir of bacteria in aquatic environment 
resources. In vitro studies demonstrated intracellular replication of F. 
tularensis within D. discoideum and A. castellanii cells. It has been 
established that crucial step in Francisella infection is entering the target 
cells by receptor mediated phagocytosis. This process has been shown to 
be meaningful in macrophages, arthropod-derived cells and amoeba cells. 
We used a water-borne amoeba A. castellanii and D. discoideum as 
surrogate macrophages as amoeba model systems to study influence of 
metabolic inhibitor methylamine on results of intracellular and extracellular 
life of F. novicida. For the first time we showed that methylamine has 
inhibitory effect on F. novicida entry and replication in D. discoideum and 
A. castellanii. The influence of different levels of infection was also 
examined and showed a dose-dependent effect on intracellular and 
extracellular infection. Moreover, methylamine was analyzed to observe 
whether in concentration of 100 mM induce cytopathogenicity in amoebae 
mentioned before. We conclude that F. novicida cannot entry and replicates 
in D. discoideum and A. castellanii after treated with 100 mM methylamine 
and that this concentration of inhibitor is not toxic to amoeba itself and can 
be used to inhibit receptor-mediated phagocytosis during Francisella 
infection.  
 
Key words: Francisella novicida, Acanthamoeba castellanii, Dictyostelium 
discoideum, methylamine  
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Sažetak 
Francisella tularensis je gram-negativni fakultativno unutarstanični 
bakterijski pathogen koji uzrokuje tularemiju u ljudi i životinja. Amebe kao 
što su A. castellanii i D. discoideum služe kao stanice domaćina za različite 
unutarstanične patogene u prirodi. U određenim dijelovima svijeta 
epidemiologija F. tularensis je usko povezana s prijenosom bolesti putem 
vode, što uključuje komarce i amebe kao glavni izvor bakterije u vodenom 
okolišu. In vitro studije su pokazale unutarstaničnu replikaciju F. novicida 
u stanicama D. discoideum i A. castellanii. Utvrđeno je da ključan korak u 
infekciji je ulazak bakterije u ciljanu stanicu mehanizmom receptorom 
posredovane fagocizote. Pokazalo se da je taj proces od velike značajnosti 
u makrofazima, stanicama člankonožaca i amebama. Amebe A. castellanii 
i D. discoideum, kao surogat makrofaga, koristili smo kao modele za 
istraživanje utjecaja metaboličkog inhibitora metilamina na razmnožavanje 
F. novicida. Prvi smo pokazali da metilamin ima inhibitorni učinak na ulazak 
i replikaciju F. novicida u stanice D. discoideum i A. castellanii. Također, 
istraživan je utjecaj infektivne doze bakterija na unutarsničnu i izvastaničnu 
replikaciju Francisella, kao i utjecaj metilamina u koncentraciji 100 mM na 
citotoksičnost u ameba. Naši rezultati pokazuju da F. novicida ne ulazi i 
replicira se u stanicama D. discoideum i A. castellanii koje su prethodno 
tretirane sa 100 mM metialminom. Navedena koncentracija nije toksična za 
same stanice te se može korisiti za sprečavanje receptorom posredovane 
fagocitoze tijekom Francisella infekcije.  
 
Key words: Francisella novicida, Acanthamoeba castellanii, Dictyostelium 
discoideum, metilamin  
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1. Introduction 
1.1. History of genus Francisella  
Since the beginning of the 20th century Francisella tularensis has been 
recognized as a human pathogen. Tularemia was first described in 1911 by 
McCoy as a plague-like disease of California ground squirrels [1]. Some 
previous reports of disease date back from 1890s from Norway where cases 
of disease were called lemming fever [2], and cases of Yato-Byo (hare 
disease) from Japan as early as 1818 [3]. The first verified clinical case 
occurred in Ohio in 1914 [4]. 
F. tularensis is a gram-negative, facultative intracellular bacterium 
that causes the fulminating zoonotic disease in humans and animals. It is 
small, asporogenous, pleomorphic and immobile bacteria. After 2 to 4 days 
of cultivation at 37 °C, Francisella colonies appear as smooth, white and 
moist in 2 mm of diameter on chocolate agar. Optimum pH for growth 
medium is between 6.8 and 7.3 [5]. This bacterium is auxotrophic for amino 
acid Cysteine [6] and grows on substrates enriched with animal proteins. 
Due to its high infectivity it is needed only 10 bacteria to cause a disease 
[5]. 
For many years, F. tularensis has been considered as a potential 
biological weapon, and in 1930s and 1940s, Japanese germ-warfare units 
examined the possibility of intentionally causing tularemia in humans. 
There were also offensive programs in both the United States and former 
Soviet Union to develop weapons containing F. tularensis. Ken Alibek, a 
former Soviet Union scientist involved in the bioweapons program, claimed 
that such offensive programs resulted in production of Francisella strains 
engineered to be resistant to vaccines and antibiotics [7]. 
The high virulence and high morbidity justify the inclusion of F. 
tularensis as an agent as the most likely biological treat agents. According 
to Centers for Disease Control and Prevention (CDC), it is designated as a 
category A Select Agent [8]. 
2 
 
1.2. The taxonomy and classification of Francisella 
tularensis  
In year 1919, Edward Francis first suggested original name of F. 
tularensis, Bacterium tularensis named after Tulare County, California [9]. 
During 1920s, bacterium was designated as Pasteurella tularensis until 
1966 when it was determined that the genus was not intently related to 
Pasteurella [10]. Later, 16S rDNA sequence analysis disclosed that 
Francisella belonged to γ-subclass of Proteobacteria [11]. Current 
taxonomy affirm that Francisella still is the only recognized genus within 
family Francisellaceae [12].  
1.2.1. Species of genus Francisella tularensis  
Five species of genus Francisella has been recognized: F. tularensis, 
F. hispaniensis, F. noatunensis, F. novicida and F. philomiragia [13]. The F. 
tularensis species causes an incapacitating disease in humans, although F. 
hispaniensis, F. novicida and F. philomiragia are less pathogenic and 
predominantly pernicious for humans with a compromised immune system 
[12,13]. Three closely related subspecies of F. tularensis have been 
identified: tularensis (Type A), holarctica (Type B) and mediasiatica.  
F. tularensis subsp. tularensis (Type A) endemic in North America is 
a cause of approximately all fatalities due to tularemia, which mortality 
rates are up to 30%.  
F. tularensis subsp. holarctica (Type B) found throughout the 
Northern hemisphere causes a milder disease with rarely occurred 
fatalities.  
F. tularensis subsp. mediasiatica found in central Asia display level of 
virulence related to strains of subspecies holarctica with rarely cause of 
human infections [13].  
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1.2.1.1. F. novicida  
In 1951, a bacterium related to F. tularensis was isolated from a 
water sample collected from Ogden Bay, Utah. Although it was originally 
classified in genus Pasteurella [14], in 1959 it was transferred to genus 
Francisella and originally designates as F. novicida. Based on biochemical 
characteristics and DNA relatedness, in 1989 F. novicida was suggested to 
constitute a subspecies of F. tularensis [15]. Today, despite genetic 
identity, genomic, ecological, virulence, pathogenic, and clinical differences 
between F. tularensis and F. novicida clearly affirm maintaining F. 
tularensis and F. novicida as separate species [16,17]. 
F. novicida type strain U112 is not virulent in immunocompetent 
humans but is highly virulent in laboratory mice. Only several bacteria 
cause tularemia and death, similar to subsp. tularensis and is likely an 
attractive model to study pathogenesis of F. tularensis. Only 12 cases of F. 
novicida-like human infection has been documented in 
immunocompromised patients [13,17]. Association with water-borne 
transmission indicates mosquitos and amebae as the potential aquatic 
reservoir of the bacteria [18] and demonstrate that F. novicida resides in 
environmental niche by propagating via mechanism that does not involve 
arthropod or mammalian hosts [17].  
1.3. Epidemiology of tularemia 
Tularemia is transmitted to humans by direct contact with infected 
animals, by arthropod bites (mosquitoes, ticks, flies), by contact with 
infected tissues and animal fluids, by ingestion of contaminated water and 
food and by inhalation of contaminated aerosols. There is no documented 
evidence for human-to-human transmission of tularemia. F. tularensis has 
been isolated from a number of different wildlife species which may act as 
vectors for transmission to humans [19]. F. tularensis subsp. tularensis is 
most commonly find in rabbits, rodents, hares and ticks, whereas F. 
tularensis subsp. holarctica is often find in ponds, streams, lakes and rivers. 
According to demonstration of F. tularensis in amoebal cysts it has also 
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been proposed that protozoa play important role as hosts in aquatic life 
cycles [19,20].  
1.3.1. Geographical distribution 
Tularemia has been reported in many countries since its first original 
description in the United States. Endemic areas have existed for a long 
time, especially in countries of the northern hemisphere [19] such as Nordic 
countries and North America, as well as in Russian Federation and Eastern 
Europe. A large outbreaks have also occurred in Germany [21], Czech 
Republic, Turkey, Finland, Sweden and France. In recent decades the rise 
in a number of the cases were remarkable in the Balkan countries, 
particularly in the period 2001-2010 with the highest annual incidence in 
Kosovo because of the negative impact of the war. Croatia followed with 
rates of 0.15 per 100,000 people. There is no documented report of 
tularemia in the Antarctica, South America, Africa, Iceland and United 
Kingdom [22]. Only few tularemia related cases and isolate of F. novicida 
has been found in Australia [19,22]. Climate change, natural disasters, 
wars, human travels and animal movements have been increasing causes 
of tularemia among the world. One study estimated that in coming decades 
global warming would cause an increase in tularemia cases [22]. 
1.3.2. Vectors 
1.3.2.1. Arthropods 
Ticks are recognized as the most important vectors in the USA, where 
at least 13 species from genera: Ixodes, Haemaphysalis, Dermacentor and 
Amblyomma have been infected with F. tularensis. Flies (Chrysops spp.) 
are prevalent vectors in California, Utah and Nevada [23]. In the former 
Soviet Union, bacteria are mostly transmitted by mosquitoes (Anopheles 
spp., Aedes spp., Culex spp.) and ticks (Ixodes spp.). In central European 
countries, such as Austria and the Czech Republic ticks Ixodes ricinus and 
Dermacentor reiculatus are considered as important vectors for the 
disease. Mosquitoes of the species A. cinereus are discussed to have a role 
as mechanical vectors for transmission of F. tularensis to humans [19]. 
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Flies of the family Tabanidae which includes true deer flies (Chrysops spp.) 
and horse flies (Tabanus spp. and Chrysozoma spp.) may serve as vector 
for disease in former Soviet Union and the USA [23].  
1.3.2.2. Mammals 
First tularemia outbreaks have been characterized in hares, prairie 
dogs and mink. Numerous terrestrial and aquatic mammals such as 
muskrats, beavers, ground squirrels, rabbits, hares and, rodents such as 
water voles and meadow voles are thought to spread F. tularensis in the 
environment. The most common vectors for the spread of disease to 
humans are the common vole (Microtus arvalis), the water vole (Arvicola 
terestris), the red-backed vole (Clethrionomys spp.) and the domestic 
mouse (Mus musculus) [19]. In central Europe, a non-rodent species such 
as hares and rabbits are suggested to be primary reservoir of tularemia and 
may spread tularemia by infecting hunters or trappers [20] . 
1.3.2.3. Environment  
F. tularensis is considered as highly resistant to external 
environmental conditions. Bacteria can survive months and years at low 
temperatures in water, soil, swamps, mud, barns, frozen meats and animal 
wastes [5,22]. If stored at -70 °C or lyophilized, virulence can be retained 
for years. F. tularensis can also survive heating at the temperatures of 42-
65 °C, in food and drinking water. Some studies have shown that F. 
novicida exponentially propagates in cow, goat, soy and chocolate milk, 
which is corresponding to results that bacteria best replicates on the 
nutrient substrates that contains amino acid cysteine [5]. 
Previous studies have shown that F. tularensis can survive and 
proliferate in amoebae living in water, Acanthamoeba castellanii, as new a 
source of infection for animals and people [5,22].  
1.3.3. Tularemia 
Tularemia is more prevalent in certain groups of people. Groups with 
a higher risk of developing disease include laboratory workers, 
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veterinarians, foresters, hikers, hunters, people from rural areas and 
people in contact with animals and meat [22].  
1.3.3.1. Clinical manifestations 
Preliminary symptoms (flu-like symptoms) such as fever, chills, 
malaise, sore throat and headache are quite nonspecific and occur after an 
incubation period of 3-5 days [24]. The clinical manifestations of tularemia 
differ because of different route of infection. Humans can get infected by F. 
tularensis through the skin, mucous membrane, respiratory and 
gastrointestinal tract [20].  
There are several clinical forms of disease including ulceroglandular, 
glandular, oculoglandular, oropharyngeal, respiratory and typhoidal 
[20,24]. In ulceroglandular form, skin or mucous membranes are often 
considered the route of infection. Normally, it results from arthropod bites, 
ticks and mosquito bites. A primary ulcer develops at the site of arthropod 
bite, followed by painful swelling of the lymph nodes. The term glandular 
tularemia pertains to a similar clinical presentation, but without primary 
skin lesion. In the most parts of the world, around 90% of cases are 
represented by glandular and ulceroglandular forms [5,20,24]. The 
oculoglandular is transmitted by patient’s fingers followed by conjunctivitis 
and lymph node enlargement [5,24].  
The oropharyngeal form of tularemia appears after the ingestion of 
contaminated water or food and presents with stomatitis, pharyngitis and 
with tonsillar involvement. The respiratory form of tularemia is often related 
to inhalation of aerosolized F. tularensis, or inhalation of dust containing 
remains from infected animals, which occurs during farming activities. 
Symptoms are often presented as a systemic illness with high fever. 
Although respiratory tularemia is the most severe form of disease, mortality 
rate in Europe is highly unusual [19,20, 24]. Typhoidal tularemia represents 
a clinical manifestation with severe systemic manifestations but without 
specific regional symptoms such as mucosal or cutaneous lesions or swollen 
lymph nodes [20,24]. 
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1.4. Francisella virulence factors 
During the past, there has been a dramatically increase in studies on 
the virulence of the highly infectious intracellular pathogen F. tularensis. 
The organism produces a capsule, an insert LPS, escapes the phagosome 
(Francisella pathogenicity island, FPI mediate phagosomal escape) to grow 
in cytosol of variety of host cell types [25]. 
1.4.1. Francisella pathogenicity island (FPI) 
Francisella pathogenicity island was first reported in 2004 when it was 
described a large cluster of genes on an island of the F. novicida 
chromosome [26]. This 30-kb island encodes 18 genes, 14 of which are 
essential for growth in macrophages. All, except pdpE and anmK genes are 
required to produce virulence phenotype in F. tularensis. This island is also 
recognizable by regions of DNA with a relatively low GC content that differs 
from that of the rest of the chromosome. Due to some proteins encoded on 
the FPI that show homology to the core components of Type VI secretion 
system (T6SSs) of other Gram-negative bacteria, it was recommended that 
the FPI encoded a T6SS [27].  
The FPI is present in single copy in F. novicida and duplicated in F. 
tularensis and F. tularensis subsp. holarctica. Because of single copy of the 
FPI and low virulence for humans, F. novicida is more tractable species for 
study and investigations of the FPI [27].  
1.4.2. Capsule  
Polysaccharide capsule are produced by bacteria to maintain the cells 
shape [28] and typically protect them from phagocytosis, complement-
mediated lysis and immune recognition. Biochemical analyses showed that 
capsule was distinct from cell wall material, and composed of lipids (51%), 
amino acids (35%) and carbohydrates (21%). Majority of studies have 
indicated that F. tularensis produces a polysaccharide capsule identical to 
the O-antigen. It is well-known that pathogens like F. tularensis manipulate 
host cell entry and mechanisms involved in intracellular trafficking to limit 
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inflammation and promote intracellular survival. Capsule can also draw out 
protective immunity, as proved by successful commercial capsule- based 
vaccines against S. pneumoniae. In addition, capsule-like substances may 
vary among different Francisella strains and can depend on culture 
conditions and environmental stimuli [29].  
1.4.3. Lipopolysaccharide (LPS) 
For most Gram-negative bacteria, lipopolysaccharide (LPS) makes up 
the outer leaflet of the outer membrane. LPS is made up of three main 
components: lipid A, O-antigen and the core oligosaccharide. Of these, lipid 
A (endotoxin) has high immunostimulatory and virulence characteristics. 
Differences in macrophage activation and virulence appeared to be due to 
lipid A alternations. The lipid A component is conserved across all 
Francisella species and all have typically loci flanked by transposases with 
lower G-C content than the rest of Francisella genome. Taken together, 
specific LPS modifications provide virulence strategy of F. tularensis, 
resulting in high infectivity and serious disease. In future, vaccine 
development efforts may need to take into account incorporating anti-LPS 
responses [29].  
1.4.4. Type IV pili 
Type IV pili are important virulence factors for Gram-negative 
pathogens such as Pseudomonas aeruginosa and Neisseria meningitides 
with important role in bacterial adhesion, aggregation, DNA uptake and 
twitching motility. The Francisella gene cluster found in those bacteria 
appear to contain 14 genes, including inner and outer membrane, ATPase 
and pilin subunit proteins. The inner or outer membrane protein deletions 
resulted in attenuation refer to requirement of many type IV pili assembly 
for Francisella virulence. In F. novicida, components of the type IV pili 
homologous genes have been described to be involved in type II-like 
protein secretion system [29]. 
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1.5. Intracellular lifestyle of F. tularensis in mammalian, 
arthropod- derived and amoeba cells 
1.5.1. Role of the T6SS in phagosomal escape and intracellular 
replication   
As previously illustrated FPI genes encode T6SS which is required for 
phagosomal escape and intracytoplasmic replication of F. tularensis in 
macrophages and necessary for virulence in animals [27,30]. The existence 
of the T6SS secretion system is affirmed by finding that VgrG and IglI 
proteins are secreted by F. novicida into the cytosol of macrophages. It has 
been recently shown that lipoprotein IglE encoded by FPI, interacts with 
other FPI proteins and localizes to the outer membrane resulting in a 
channel formation. The T6SS assembles a phage tail-like injectosome to 
translocate effector proteins crosswise the host cell membrane and two 
bacterial membrane into the cytosol of the host cell. The most researched 
FPI protein, global regulator MglA and IglC are crucial for the capacity of 
Francisella to escape Francisella-containing phagosome (FCP) into the 
cytoplasm [30].  
1.5.2. Intracellular life of F. tularensis in macrophages 
F. tularensis invade and multiply within various cells, including 
neutrophils, alveolar epithelial cells, and hepatocytes, but macrophages are 
considered its primary target in vivo [27].  
Francisella enters into macrophages by binding to surface receptors 
and looping phagocytosis through “lipid rafts” (cholesterol-rich membrane 
domains) with caveolin-1 [30]. Lipid-rafts associated components and 
cholesterol, as a key regulatory and structural element for the integrity of 
lipid-rafts, are incorporated into FCP membrane during entry and initial 
phase of intracellular infection of host cells [31]. Following uptake, 
Francisella reside within the FCP which matures to an early endosome state 
characterized by Rab-5 and early endosome antigen 1 (EEA1). The FCP 
matures into late endosome and therefore acquires late endosomal markers 
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Rab7, CD63, mannose-6-phospathe, and lysosomal associated proteins 
(LAMP-1 and LAMP-2). Ultimately, the late endosome become acidified 
through the acquisition of the vATPase proton pump that imports hydrogen 
inside the vacuole. To avoid lysosome-mediated killing, bacteria escapes 
from the FCP to the cytosol (Figure 1A) [30,31].  
Despite the fact that brief time spent in the FCP is dynamic step in 
the infection for Francisella by evading host antimicrobial defense 
(antimicrobial peptides and reactive oxygen species), recent study has 
brought controversy about Francisella vacuolar escape kinetics that vary 
from 15 min to 8 h after infection [30,31]. It appears that Francisella 
escape from phagosome is requisite to intracellular proliferation and is 
crucial in its intracellular life cycle [31]. Eventually, the bacterial escape 
from the host cell is followed by cell-to-cell transmission, or by inducing 
host cell death (pryoptosis, apoptosis) [32]. 
1.5.3. Intracellular life style of F. tularensis in arthropod-
derived cells  
Although little is known about the molecular interaction of Francisella 
with arthropod vectors, transmission of tularemia borne by vector has a 
very important role in pathogenesis. Recent studies have shown that F. 
tularensis induce infection and kills adult Drosophila files. The intracellular 
lifestyle of bacteria within human macrophages is similar to arthropod-
derived cells. F. tularensis temporarily reside within acidified phagosome 
that consequently matures to a late endosomal stage, accompanied by 
bacterial escape into the cytosol [30,33]. 
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1.5.4. Intravacuolar proliferation of F. tularensis within 
amoeba cells 
Previous studies have shown that Francisella enters and multiply 
within Acanthamoeba castellanii [34], Hartmannella vermioformis [18] and 
Dictyostelium discoideum cells [32,34]. After being engulfed by 
trophozoites [34], Francisella resides and replicates within amoeba cells in 
non-acidifies, membrane-bound vacuoles known as Francisella-containing 
vacuoles (FCVs) [31,36]. In contrast to mammalian and arthropod-derived 
cells, bacteria do not escape from FCV for replication in water-borne 
amoebae (A. castellanii and H. vermioformis), which is the main difference 
between these host cells (Figure 1B) [30,32,36]. In addition, one study has 
shown that FCVs did not acquire the dye that concentrates in acidified 
vesicles during the F. novicida infection of amoebae [37]. It has also been 
indicated that lysosomal fusion within A. castellanii is blocked by F. 
novicida. Interestingly, the IglC (FPI-encoded protein) does not serve for 
phagosomal escape in the water-borne amoebae but is important growth 
factor inside bacteria’s vacuoles [18,32]. 
 Studies have also illustrated replication of F. novicida within H. 
vermioformis in non-acidified vacuoles [18]. The fact that bacteria was 
observed in cysts of A. castellanii suggests the importance of the protists 
in sustaining the Francisella life-cycle and its long-term survival in aquatic 
environment [32]. Even though, amoebae serve as a training ground for 
other bacterial pathogens, it has been shown that F. novicida infected 
amoebae does not enhance bacterial virulence in mice, which may result 
from difference in virulence strategies and life cycles in macrophages and 
amoebae [38].  
On the other hand, there is a model to study Francisella infection 
using the amoeba D. discoideum as a macrophage surrogate. This study 
points out similarities between infection of D. discoideum with F. 
noatunensis and Francisella infection of mammalian macrophages, such as 
phagocytosis, phagosomal maturation with acidification of this 
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compartment, and consequently bacterial escape and replication into the 
cytosol, and autophagy, thereby presenting Dictyostelium as a useful model 
to examine the interactions between Francisella and its phagocytic host 
cells [32,35]. 
 
  
Figure 1. Intracellular proliferation of Francisella within macrophages (A) and amoebae cells 
(B). (A) After phagocytosis by macrophages, Francisella reside in the FCP which matures in early (EEA1 
and Rab 5) and late (Lamos and Rab7) endosomal stage. The FCP become acidified by the vATPase 
proton pump with the result of bacterial escape into the cytosol and replication. (B) After phagocytosis 
by amoebae, bacteria reside and replicate in intact vacuole. “Retrieved from: M. Ozanic et al, “The 
Divergent Intracellular Lifestyle of Francisella tularensis in Evolutionarily Distinct Host Cells,” PLoS 
Pathog., vol. 11, no. 12, pp. 1–8, 2015.” 
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1.6. Model to study tularemia  
1.6.1.  Acanthamoeba castellanii  
A. castellanii belongs to genus Acanthamoeba that was first 
established in 1930 by Volkonsky [39]. The genome of 45 Mb makes A. 
castellanii suitable for the wide range of studies. Free-living Acanthamoeba 
spp. are commonly found in natural sources such as soil, lakes, seawater 
and fresh water. They are also isolated from chlorinated water from 
swimming pool, jacuzzi tubs, hydrotherapy pools, tap water, contact lens, 
dental treatment units and heating and air conditioning units [36,39,40]. 
Several Acanthamoeba species have ability to cause a human disease, 
including A. castellanii. Free-living amoeba feed on fungi, bacteria and 
algae by phagocytosis. Acanthamoeba species can serve as environmental 
hosts for large number of intracellular pathogens, including F. tularensis, 
Legionella pneumophila, Listeria monocytogenes, Chlamydia, Coxiella 
burnetii, many Mycobacterium spp., and Escherichia coli [34,36,39]. 
1.6.1.1. Life cycle of A. castellanii 
A. castellanii adopts a bi-phasic life cycle, an active vegetative 
trophozoite stage and dormant cyst stage [34,39,41], both with a diameter 
of 13-23 µm [42]. During trophozoite stage amoeba replicates by binary 
fission under optimal culturing conditions such as food supply, neutral pH 
and ~30 °C [42], has a doubling time ranged from 8 to 18 h (Figure 2). 
The amoeba are highly motile producing short, spine-like projections known 
as acanthopodia, and have ability to use chemotaxis to “hunt” [41]. When 
exposed to a harsh conditions, amoebae differentiate into a double-walled 
cyst form (Figure 2) [42].  
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1.6.1.2. Experimental approaches of A. castellanii 
A. castellanii imply as a good training model eukaryote due to its rapid 
growth, as short as 8 h at 30 °C, in complex media, and its effective 
encystment on starvation. Amoebic motility and phagocytosis provide new 
insights in examining cellular structure and function aspects. Indication that 
bacterial pathogens such as F. tularensis can survive in A. castellanii cysts 
for at least 3 weeks after infection [43], gives special impact on future 
Francisella studies on protozoa. Moreover, amoebae are characterized by 
contractile vacuoles, wherein F. tularensis seems to replicate [34,41]. The 
bacteria are able to survive inside A. castellanii as endosymbionts and use 
of amoeba as vectors for their dissemination [34]. Despite polyploid 
genome complexity and no genetic manipulation tools, a water-borne A. 
castellanii remains possible model for environmental reservoir [32,41].
 
Figure 2. The life cycle of A. castellanii. Amoeba life cycle stages: active vegetative trophozoite 
and dormant cyst stage. In conditions with nutrients and without drug pressure, amoeba replicates 
during trophozoite stage by binary fission. After exposure to a stress conditions, drug pressure and 
the lack of nutrients, amoeba differentiate into double-walled cyst form. 
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1.6.2. Dictyostelium discoideum  
The social amoeba, D. discoideum is a member of a group Dictyostelia 
which belong to a supergroup Amoebozoa, one of the major divisions of 
eukaryotes [44,45]. The genome of 34 Mb, about 100 times smaller than 
human, makes D. discoideum as increasingly used model for the study of 
genes that are defective in human diseases [41]. There are ~120 species 
of Dictyostelia subdivided into four major groups, whereas D. discoideum 
belongs to group 4, species that have ability to secrete cyclic adenosine 
monophosphate (cAMP) to serve as a chemoattractant for aggregation 
[41,45]. Social amoebae are commonly found in a wide range of natural 
habitats such as from arctic to tropical soil, and from rainforest to desert 
with most prevalence in the leaf litter , which is the supplied source of their 
bacterial food [45]. Considering the fact that amoebae can be infected by 
Francisella, Legionella, Mycobacteria, Pseudomonas or Klebsiella, makes 
Dictyostelium as a suitable cellular model for intracellular replication of 
human pathogenic bacteria [32].  
1.6.2.1. Life cycle of D. discoideum 
The D. discoideum life cycle is fast at just 24 hours [45] with the 
narrow temperature tolerance of 20-25 °C [41]. The amoeba replicates by 
mitotic division of only one amoebae and is feeding on bacteria taken up 
by phagocytosis [41]. When food runs out D. discoideum utilize one of three 
survival strategies. The amoebae come together to assemble a fruiting 
structure, in which a part of cells are sacrificed to form a stalk and 
remainder differentiate into solid dormant spores. After single cell growth, 
amoebae cells stop proliferating and start chemotactic aggregation in 
response to cAMP signals (Figure 3A,B), thereby forming a multicellular 
mounds (Figure 3C). Movement of the cells underneath cause a toppling 
over of an emerging column of cells to form a slug (Figure 3D). After 
migration to the top layer of the soil, slug build the fruiting structure (Figure 
1E,F). At the final stage of morphogenesis a formed fruiting body structure 
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composed of a tapered column of stalk cells with a spherical mass of spores 
carried aloft (Figure 1G) [45].  
1.6.2.2. Experimental approaches of D. discoideum 
The D. discoideum can be easily and cheaply cultured in the 
laboratory on the bacterial lawns on agar [45], whereby some strains e.g. 
Ax2 can thrive in liquid medium containing peptone, glucose or in a defined 
mixture of vitamins and amino acids through micropinocytosis [41,45]. This 
facilitates the purification and isolation of cellular products for proteomics 
and biochemical analysis. Regarding amoeba life cycle its multicellular 
structures are transparent, allowing the visualization of gene expression 
and cell movement [45].  
Figure 3. The life cycle of D. discoideum. (A) Starving amoebae secrete pulses of cAMP, that 
(B) cause the chemotactic aggregation of cells forming multicellular mounds. (C) Cell movement 
underneath the mound cause a formation of a tipped mound. (D) A mound then develops into a 
slug. (E) After a slug migration (F) it undergoes fruiting body formation and (G) differentiation of 
cells into spores, stalk cells and structures for their support. (H) After dispersion to nutrient-rich 
habitats, formed spores germinate and (I) continue proliferation as individual amoebae. “Retrieved 
from: P. Schaap, “Evolutionary crossroads in developmental biology: Dictyostelium discoideum.,” 
Development, vol. 138, no. 3, pp. 387–96, Feb. 2011.”) 
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D. discoideum cells are easy to manipulate from biochemical and 
genetic level using integrating and extrachromosomal expression plasmids. 
Due to their haploid genome, knockout cell lines or alteration of a gene of 
interest can be easily generated by homologous recombination [32,41,45]. 
The complete genome sequence of D. discoideum, intrinsic biological 
features and molecular genetic tools of amoebae allow to research many 
fundamental cellular processes [41].  
Owing to these experimental approaches with high similarities with 
human phagocytes, D. discoideum has become primary organism in which 
to study essential processes in cell biology, such as phagocytosis, 
phagosomal maturation, autophagy, actin cytoskeleton [32]  chemotaxis, 
cytokinesis, vesicle trafficking and cell motility [45]. Furthermore, 
Dictyostelium-Francisella system is a great addition to present models of 
Francisella infection and facilitates detailed dissection of host-pathogen 
interactions [35].  
1.7. Approaches for treatment of tularemia  
1.7.1. Antibiotic treatment 
The antibiotic classes recommended for tularemia treatment are the 
aminoglycosides, the tetracyclines and the fluoroquinolones. New data 
indicate that among fluoroquinolones, ciprofloxacin and levofloxacin are 
rapidly and strongly bactericidal in cell models and are extremely effective 
in curing F. tularensis infection in mice. In contrast, tetracycline doxycycline 
is considered less effective due to its bactericidal result only in cell models 
[46,47].  According to WHO guidelines [19], the aminoglycosides, 
especially streptomycin and gentamicin, are still considered the most 
trustworthy treatment of severe tularemia cases, including the typhoidal 
and pneumonic forms, due to its lower relapse rates and better outcomes 
of disease [46,47]. Moreover, the macrolides, such as azithromycin, could 
be an alternative treatment in patients infected with F. tularensis type A 
and B, which are erythromycin-susceptible strains, including pregnant 
woman and children [46].  
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1.7.2. Vaccines 
In 1900s, several vaccines against tularemia were developed, 
including F. tularensis Live Vaccine Strain (LVS) [48]. Despite that the LVS 
vaccine retains toxicity in animals and humans, it is efficient in humans, 
thereby serving as gold standard for future vaccine efficacy studies [49].  
Since 2001, several promising LVS vaccine candidates have been 
developed including LVS mutants, F. tularensis type B mutant, LVS ΔcapB 
with overexpressed F. tularensis T6SS proteins, a LVS ΔcapB-rLm/IglC 
heterologous prime-boost vaccine, and a SCHU S4 mutant with single 
deletion (ΔpurMCD). These new vaccines have been better and greatest 
when administered by the intranasal. Nevertheless, application through 
another respiratory route has displayed higher significance, but raised 
additional safety issues. Regardless these outcomes, vaccines that are at 
least as efficacious as LVS, and safer, have been developed, and they are 
promising candidates for future advanced non-human primate model 
studies and human safety trials [49]. 
1.7.3. Cytoskeletal and metabolic inhibitors 
As mentioned, crucial step for Francisella infection and replication in 
mammalian and amoeba cells is phagocytosis by macrophages and 
amoebae.  Due to revealed mechanism and receptors involved in 
phagocytosis, some potential inhibitors have demonstrated significance 
impact on entering bacteria into cells. 
1.7.3.1. Cytochalasin D 
A small organic fungus-derived compound, cytochalasin D (CytoD), is 
widely used for studying the role of actin dynamics in numerous cellular 
process, including phagocytosis, migration, division and morphological 
changes. CytoD inhibits, not only the depolymerization and polymerization 
of actin sub-units by binding with high affinity to the ends of actin filaments, 
but also inhibits interaction between G-actin and cofilin, including 
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disassembly of cofilin-mediated actin filament [50]. It has been 
demonstrated that treating U-937 and macrophages CytoD effectively 
inhibits the entry of L. pneumophila and consequently preventing 
replication of this intracellular bacteria. In the protozoa A. castellanii and 
H. vermioformis, CytoD has almost no effect on entry and replication of L. 
pneumophila [51,52].  
1.7.3.2. Methylamine 
Methylamine is a small organic compound with a molecular formula 
of CH3NH2 that belongs to the group C1 alkylamine [53], which are easily 
synthesized by interaction of methanol (MeOH) and ammonia (NH3) over a 
catalyst [54]. Methylamines are used as intermediates for a wide range of 
agricultural chemicals (e.g. herbicides, fungicides, insecticides, biocides 
and miticides), pharmaceuticals (e.g. ephedrine), animal nutrients,  
explosives, surfactants and water treatment [53].  
 
In biological aspects, methylamine inhibits transglutaminase, a 
plasma membrane enzyme included in the aggregation of ligand-receptor 
complexes, thereby inhibiting receptor-dependent endocytosis [52,55]. 
This inhibitor is also characterized as adsorptive inhibitor of receptor-
mediated pinocytosis in macrophages, fibroblasts [56] and amoeba cells 
Figure 4. Molecular structure of methylamine. (A)2D molecular structure of 
methylamine. (B)3D molecular structure, ball and stick model of methylamine. Drawings of 
molecular structures are made with MarvinSketch command line program.  
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[51,52]. Methylamine has been used to inhibit intracellular development 
and internalization of Chlamydia trachomatis into McCoy cells [57], and for 
inhibition of adsorptive endocytosis of Semliki Forest virus in BHK-21 cells 
[58]. Previous studies have shown that the ability of L. pneumophila to 
multiplicate in H. vermioformis and U-937 cells was inhibited by a dose-
dependent effect of methylamine, which means that concentration of 100 
mM completely inhibit multiplication of bacteria in amoebae. They have also 
established that concentrations of methylamine higher than 250 mM cause 
encystation of amoebae within 24 h, whereas lower concentrations are not 
toxic to either the U-937 monocytes and amoebae [52]. Some experiments 
have also indicated that when treated with 10 µM, 1mM and 10 mM 1 hour 
before and 3 hours after infection, methylamine incompletely inhibit entry 
of F. novicida into D. discoideum cells (unpublished data). 
 Moreover, other study has indicated that methylamine in 
concentration of 100 mM greatly reduce entry and replication of L. 
pneumophila into A. castellanii into early stages of infection when added 1 
h prior to inoculation with bacteria [51]. Considering L. pneumophila and 
F. tularensis similarities of life cycle in protozoa cells [36], methylamine 
could be a potential cytoskeletal and metabolic inhibitor of entry and 
multiplication of Francisella within various amoeba cells, such as A. 
castellanii and D. discoideum.  
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2. Objective 
Examine the influence of methylamine in concentration 100 mM on 
extracellular and intracellular growth of F. novicida in D. discoideum and A. 
castellanii cells. 
Examine whether different doses of infection (MOI) have influence on 
extracellular and intracellular growth of F. novicida in D. discoideum and A. 
castellanii cells after treatment with 100 mM methylamine.  
Examine the influence of methylamine in concentration 100 mM on 
LDH release from D. discoideum and A. castellanii cells infected with 
different MOI of F. novicida.  
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3. Materials and methods 
3.1. Materials 
3.1.1. Bacteria and amoeba cultures 
The wt strain of F. novicida was obtained by the courtesy of prof. 
Andreas Sjostedta (Umei University, Umea, Sweden). D. discoideum strain 
AX2 was obtained by the courtesy of prof. Michaela Steiner (Technische 
Universitat Braunschweig, Germany). A. castellanii was obtained from 
American Type Culture Collection, 30234.  
3.1.2. Nutrient substrates and other materials  
The HL5 medium for growth of Dictyostelium was prepared by 
dissolving 7.15 g of Yeast extract (Oxoid), 14.3 g of Bacterial Protease 
Peptone (Biolife), 1.28 g Na2HPO4 in 900 mL of sterile distilled H2O. The pH 
was adjusted to 7.5 with sterile solutions of 10 N KOH. After autoclaving 
and cooling, 15.4 g of glucose monohydrate was dissolved in 100 mL of 
sterile distilled H2O and sterilized by filtration through a 0.22 µm filter. 
Concentrated sorens buffer (200x, TCS Biosciences Ltd.) was diluted with 
sterile distilled H2O 1:200. The pH buffer was checked before use.  
The ATCC 30234 medium for growth of Acanthamoeba was prepared 
by dissolving 1 g of Yeast extract, 20 g of Bacterial Protease Peptone in 
sterile distilled H2O. Inorganic stock solutions were prepared separately in 
order and amount of 8 mL 0.05 M CaCl2, 10 mL 0.4 M MgSO4 x 7H2O, 10 
mL 0.25 M Na2HPO4 x 7H2O, 10 mL 0.25 M KH2PO4 and 10 mL 0.005 M 
Fe(NH4)2(SO4)2 x 6H2O. After autoclaving, cooling and mixing, 18 g of 
glucose monohydrate and 1 g of Na3C6H5O7 x 2H2O was dissolved in 50 mL 
of sterile distilled H2O and sterilized by filtration. After mixing, the pH of 
the complete medium was adjusted to 6.5 with sterile solutions of 1N HCL 
or 1N Na OH. Final volume was brought up to 1L by the addition of sterile 
distilled water.  
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Triton X-100 (0.9 %), a non-ionic surfactant which causes 
permeabilization of the living eukaryotic cell membrane was used to release 
intracellular bacteria from amoeba.  
To assay the influence of methylamine on F. novicida growth kinetics 
in amoeba, it was used in concentration of 100 mM. 
3.2. Methods 
3.2.1. Cultivation of F. novicida  
F. novicida was grown on buffered charcoal-yeast extract (BCYE) agar 
at 37 °C with 5 % CO2 atmosphere.  
3.2.1.1. Gramm staining for identification of bacteria 
Pure culture for stained with Gramm. 
3.2.2. Cultivation of amoeba 
3.2.2.1. Cultivation of D. discoideum  
D. discoideum was cultivated in HL5 medium on 25 °C. Since we 
needed 1 x 105 cells/mL, the exact number of cells was counted using 
Neubauer chamber. Cells were distributed in microtiter plates with 96 wells 
in HL5: Sorensen (1:1) medium and were left overnight to adhere. One 
Figure 5. F. novicida is gram-negative in its staining morphology. 
Representative stained microscopic image of F. novicida. 
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hour before infection cells were treated with 100 mM methylamine and 
incubated for 1 hour on 25 °C.  
3.2.2.2. Cultivation of A. castellanii  
A. castellanii was cultivated in ATCC 30234 medium with glucose on 
25 °C. Since we needed 1 x 105 cells/mL, the exact number of cells was 
counted using Neubauer chamber. Cells were distributed in microtiter 
plates with 96 wells in ATCC 30234 medium without glucose and were left 
overnight to adhere. One hour before infection cells were treated with 100 
mM methylamine and incubated for 1 hour on 25 °C. 
3.2.2.3. Microscopy determination of amoeba 
Amoebae were cultivated in their growth medium and examined 
under florescence microscopy. 
 
Figure 6. Cultivation of D. discoideum cells. Representative microscopy 
images of D. discoideum cells. Scale bar= 20 µm. 
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3.2.3. Spectrophotometric determination of the number of 
bacteria 
Bacteria were picked up from agar using sterile loop and were stirred 
in HL5: Sorensen (1:1) and ATCC medium without glucose. Optical density 
(OD) of samples was measured in cuvette on wavelength 580 nm. Sterile 
distilled water was used as control. According to bacterial growth curve, 
ODsample=1 refers to concentration of 1 x 109 CFU/mL, as determined by 
previous experiments.  
Amoeba D. discoideum and A. castellanii were infected with F. 
novicida at a multiplicity of infection (MOI) 5, 10 and 100. The MOI of 5, 
10 and 100 represents 5, 10 and 100 bacteria inoculated per one cell.  
Figure 7. Cultivation of A. castellanii cells. Representative microscopy 
images of A. castellanii. Scale bar=20 µm. 
 
26 
 
3.2.4. Infection of D. discoideum and A. castellanii  
Cells were allowed to adhere to the bottom of the wells. Cells were 
infected with 10 µL bacterial suspension (5 x 107 CFU/mL, 108 CFU/mL and 
109 CFU/mL) to achieve the dose of 5 x 105 CFU/mL, 106 CFU/mL and 107 
CFU/mL. Suspensions were centrifuged on 1200 rpm for 3 minutes and 
incubated for 1 hour on 27 °C. After incubation cells were washed (2x) with 
saline to remove extracellular bacteria. After second wash the cells were 
added HL5: Sorensen (1:1) medium or ATCC 30234 medium without 
glucose and medium with 100 mM methylamine. This time point was 
considered as time zero.  
Two hours after infection 160 µL of media was removed into another 
well (extracellular bacteria). The 50 µL of media was taken for 
measurement of LDH. Cells were treated for 10 minutes with Triton X-100 
(0.9 %) to destroy the cell membrane and release the intracellular bacteria. 
10-fold dilutions were made and 10 µL of suspension was plated on BCYE 
agar. Plates were incubated for 2 days on 37 °C. All the steps were repeated 
twice after 4, 24, 48 and 72 hours after infection.  
3.2.5. The CytoTox 96® Non-Radioactive Cytotoxicity Assay 
The CytoTox 96® Assay was used to quantitatively measure lactate 
dehydrogenase (LDH), a stable cytosolic enzyme released upon cell lysis. 
The half-life of released LDH from cells into the surrounding medium is 
about 9 hours. Released LDH in culture supernatants was measured with a 
30-minute couple enzymatic assay, which resulted in the conversion of a 
tetrazolium salt (iodonitro-tetrazolium violet; INT) into red formazan 
product. The amount of color formed is equal to the number of lysed cells. 
Visible wavelength absorbance data were collected using a standard 96-
well plate reader. To form the CytoTox 96® Reagent, 12 mL of Assay Buffer 
was defrosted and warmed at room-temperature and was added to a bottle 
of Substrate Mix. Supernatant samples (50 µL) were transferred to a 96 
well plate and 50 µL of Substrate Mix was added to each well. Plate was 
covered with foil to protect it from light and incubated for 30 minutes at 
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room temperature. After incubation 50 µL of Stop Solution was added to 
each well and recorded at the absorbance at 490 nm within 1 hour.  
  
 
 
 
Figure 8. Release of LDH from damaged cells is measured by 
supplying lactate, NAD+ and INT as substrates in the 
presence of diaphorase. Generation of a red formazan product is 
proportional to the amount of LDH released and therefore the number 
of lysed cells.  
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Figure 9. The Cytotox 96® Non- Radioactive 
Cytotoxicity Assay protocol. Supernatant samples 
were transferred to a 96 well plate and an equal volume 
of Cytotox 96® Reagent was added to each well and 
incubated for 30 minutes. Stop Solution was added, and 
absorbance signal was measured at 490 nm in a plate 
reader.”Retrived from: Promega Corporation, “CytoTox 
96 Non-Radioactive Cytotoxicity Assay,” Promega Tech. 
Bull. 163, pp. 1–14, 1999.” 
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4. Results 
4.1. Methylamine in concertation of 100 mM inhibits 
intracellular replication of F. novicida in D. discoideum  
Receptor-mediated phagocytosis seems to be the crucial step for 
Francisella infection and replication in macrophages [31] and amoeba cells 
[34,35]. Because of apparent importance of membrane receptor-complexes 
we examined the methylamine, inhibitor of Francisella entrance to cells. 
Amoebae cells were treated with 100 mM methylamine 1 h prior to infection 
with F. novicida at MOI 5, 10 or 100. After infection, supernatant was 
separated for further examination of extracellular bacteria and cells were 
washed (x2) with saline and treated with Triton X-100 to release 
intracellular bacteria. The F. novicida growth kinetics was determined by 
plating suspensions onto BCYE agar at the time point 2, 4, 24, 48, 72 h 
post infection.  
Our results showed that methylamine in concentration of 100 mM has 
a weak influence on extracellular replication of F. novicida in D. discoideum 
and differ among different MOI. There was a slight difference in the 
extracellular growth of bacteria within untreated amoeba cells and those 
treated with methylamine when comparing different doses of infection 
where 4 h p.i. (MOI 10 and 100) and 5 h p.i. (MOI 5) was almost 10-fold 
(Figure 10A,B) and 100-fold (Figure 10C) increase in bacteria in the 
absence of inhibitor with typical decline in numbers 48 h after infection. In 
contrast, it is inexplicable why bacteria persisted longer in media with 
methylamine and continue to multiply 48 h p.i. (Figure 10). Our results 
correspond to difference between MOI where extracellular bacteria reached 
up to 1011 CFU/mL (Figure 10A), 1012 CFU/mL (Figure 10B) and 1014 
CFU/mL (Figure 10C).  
Opposed to that, F. novicida did not grow within D. discoideum after 
treatment with 100 mM methylamine, with no detection in any time point, 
but multiplied to 106 CFU/mL (MOI 5 and 10) and more (MOI 100) in the 
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absence of methylamine with typical decline in numbers 48 h after infection 
(Figure 10).This indicates that intracellular multiplication of bacteria was 
completely inhibited in amoeba by methylamine after added 1 h before 
infection. There is also a difference among MOI where bacteria (MOI 5 and 
10) started to multiply intracellularly at 4 h p.i. (Figure 10A,B) but 
proliferate from time point 0 when added 100 bacteria per cells (Figure C). 
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Figure 10. The growth kinetics of F. novicida in D. discoideum following different 
doses of infection (A) MOI 5, (B) MOI 10 and (C) MOI 100. The amoeba cells were 
treated with 100 mM methylamine for one hour followed by infection with F. novicida and 
determination of the number of intracellular or extracellular bacteria on BCYE agar. The 
error bars represent standard deviations of duplicate samples and results shown are 
representative of two independent experiments. 
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4.2. Methylamine in concertation of 100 mM inhibits 
intracellular replication of F. novicida in A. castellanii 
The extracellular replication of bacteria in the presence of A. 
castellanii was also followed in this study. Although in first 24 h p.i. bacteria 
replicated in medium with presence of methylamine, there was a significant 
10,000-fold (Figure 11A) and more (Figure 11B,C) increase in number of 
extracellular bacteria in the absence of methylamine which were observed 
24 hours after infection. These results imply that inhibitors, such as 
methylamine, could be toxic for F. novicida and therefore have long-term 
inhibitory effect on extracellular bacterial proliferation under favorable 
conditions. There was also a variation in extracellular growth kinetics 
between different MOI with corresponding values 1016 CFU/mL for MOI 5 
(Figure 11A),1018 CFU/mL for MOI 10 (Figure 11B) and more than 1018 
CFU/mL for MOI 100 (Figure 11C).  
In untreated cells F. novicida multiply intracellularly within A. 
castellanii up to 105 CFU/mL with typical decline in numbers after 3 days 
after infection (Figure 11). Bacteria did not grow in amoebae that have 
been pretreated with 100 mM methylamine, indicating influence of this 
inhibitor on receptor-mediated phagocytosis. There is also a difference of 
intracellular proliferation of bacteria among different doses of infection 
where with infection dose of 5 or 10 bacteria started multiplication 24 h p.i. 
(Figure 11A,B) and 4 h p.i. when cells were infected with MOI of 100 (Figure 
11C). This signifies that bacteria proliferate earlier when added higher 
infective doses. 
These results demonstrate significance of cell membrane receptors in 
F. novicida infection of D. discoideum and A. castellanii and consequently 
illustrate the role of methylamine in inhibition of transglutaminase, thereby 
inhibiting receptor-dependent phagocytosis and preventing further 
development of bacterial infection.  
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Figure 11. The growth kinetics of F. novicida in A. castellanii after different dose 
of infection (A) MOI 5, (B) MOI 10 and (C) MOI 100. The amoeba cells were treated 
with 100 mM methylamine for one hour followed by infection with F. novicida and 
determination of the number of intracellular or extracellular bacteria on BCYE agar. The error 
bars represent standard deviations of duplicate samples and results shown are 
representative of two independent experiments. 
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4.3. Methylamine does not affect induction of 
cytopathogenicity in D. discoideum cells infected with 
F. novicida 
Cytopathogenic response of cells infected with F. tularensis are 
characterized by morphological changes such as lactate dehydrogenase 
(LDH) release. Induction of cytopathogenicity is essential for escape form 
phagosome and cytosolic replication of bacteria [59]. We examined the 
cytotoxicity of methylamine, inhibitor of phagocytosis, by testing the ability 
of inhibitor to affect the induction of cytopathogenicity (LDH release) in D. 
discoideum and A. castellanii infected with F. novicida. After treatment with 
100 mM methylamine and infection of amoeba cells with F. novicida, the 
supernatants were sampled at 2, 4, 24, 48 and 72 h and examined for the 
presence of the LDH. The results were reported in comparison to non-
treated infected cells and treated with 100 mM methylamine after different 
doses of infection (MOI 5, 10, 100).  
Methylamine did not induce significant reduction of LDH release from 
infected D. discoideum. With infection dose of 5, at 2 and 4 h after infection 
the LDH levels in supernatant of untreated cells differed from that of cells 
treated with 100 mM MA (2 h p.i. P= 0.032, 4 h p.i. P= 0.007), whereas 
24, 48 and 72 h p.i. there was no significant difference in comparison to 
treated and untreated cells, which is consistent with results of the 
extracellular growth (Figure 12A). At infection dose of 10, LDH levels of 
untreated cells did not differ much from that of treated with MA with 
significant difference 2 and 72 h (2 h p.i. P= 0.028, 72 h p.i. P= 0.025) 
(Figure 12B). When cells were infected with MOI 100, the LDH release did 
not differ from untreated in comparison to MA treated cells with only 
significance at 2 and 24 h post infection (2 h p.i. P=0.038, 24 h p.i. P= 
0.010) (Figure 12C). The LDH release from uninfected cells treated with MA 
was correlating in comparison with F. novicida infected cells treated with 
MA among all doses of infection (MOI 5, 10 and 100) (unpublished data). 
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Figure 12. The LDH release from D. discoideum cells after pretreatment with 100 
mM methylamine and different dose of infection (A) MOI 5, (B) 10 and (C) 100. 
Culture supernatants of infected D. discoideum cells were sampled and tested for LDH 
activity at 2, 4, 24, 48 and 72 h after infection. The error bars represent standard 
deviations. Statistical significance was determined using Student’s t test. P < 0.05 was 
considered significant in comparison to the untreated cells *. 
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4.4. Methylamine does not affect induction of 
cytopathogenicity in A. castellanii cells infected with F. 
novicida 
The LDH levels in supernatant of infected and untreated A. castellanii 
did not differ from those treated with 100 mM methylamine. At the infection 
dose 5, there was no significant difference between LDH release of 
untreated cells and treated in any time point of infection (Figure 13A). 
When cells were infected with an MOI of 10, LDH levels in supernatant did 
not vary much among treated and untreated cells with significant difference 
at 24 and 72 h after infection (24 h p.i. P= 0.022, 72 h p.i. P= 0.0505) 
(Figure 13B). In the infection dose of 100 cells per bacteria, the LDH release 
did not differ between untreated and MA treated cells with only one 
significance at 48 h after infection (48 h p.i. P= 0.041) (Figure 13C). 
Increasing MOI from 5 to 100 comparatively follow enhancement trend in 
LDH levels in supernatant due to increase in extracellular and intracellular 
growth of bacteria.  
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Figure 13. The LDH release from A. castellanii cells after pretreatment with 
100 mM methylamine and different dose of infection (A) MOI 5, (B) 10 and 
(C) 100. Culture supernatants of infected A. castellanii cells were sampled and tested 
for LDH activity at 2, 4, 24, 48 and 72 h after infection. The error bars represent 
standard deviations. Statistical significance was determined using Student’s t test. P 
< 0.05 was considered significant in comparison to the untreated cells *. 
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5. Discussion 
Receptor-mediated phagocytosis appear to be necessary for 
Francisella entry and intracellular replication within macrophages [31], 
arthropod-derived [33] and amoebae cells [34,35]. Therefore may studies 
have been carried out in contest to examine the importance of inhibitors, 
such as methylamine [51,52,55,57,58] and cytochalasin D [50,51,52], on 
their influence on receptor-dependent endocytosis and pinocytosis. To 
study Francisella infection a less virulent strain F. novicida was used due to 
many similarities to type A strain, such as infectivity, intracellular life cycle 
and genome sequence [31]. Because of attenuation of this strain in healthy 
humans, and high infectivity in laboratory mice, makes F. novicida safer 
and more tractable mechanism for understanding F. tularensis infection 
[17]. Considering F. novicida association with aquatic environment 
emphasize significance of water-borne transmission animals, such as 
mosquitoes and amoebae, in providing survival and proliferation of bacteria 
in water. This suggests that such animals serve as the potential long-term 
aquatic reservoir of the bacteria in nature [18]. Thereby A. castellanii, a 
water-borne amoeba [34,43], and social amoeba, D. discoideum, with 
many resemblance with Francisella-macrophages infection [35], seems to 
present as a useful models in examination of F. tularensis infection 
mechanism for aquatic environment. 
D. discoideum amoebae provide ethically unproblematic and cost-
effective models to measure bacterial virulence and host resistance with 
human pathogens such as Mycobacterium, Pseudomonas and Legionella. 
This amoeba has also been used as a host model to screen for anti-virulence 
compounds in Mycobacterium, such as inhibitors of mycobacterial sliding 
motility, in order to develop new antibacterial treatments [60]. This system 
has also been used for identification of compounds inhibiting Pseudomonas 
infectivity [61]. Our previous experiments have indicated that methylamine 
in concertation of 10 µM, 1mM and/or 10 mM incompletely inhibit F. 
novicida entry in D. discoideum when added 1 hour before and 3 hours 
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after infection but does not affect intracellular replication of bacteria 
(unpublished data). Due to these findings we increased the concentration 
to 100 mM MA which resulted in complete inhibition of intracellular growth 
of F. novicida in D. discoideum with no CFU detection in any time point. 
Opposite of that, bacteria reached up to 106 CFU/mL and more in the 
absence of inhibitor with typical decline in numbers 48 h after infection. 
This indicates that methylamine completely blocks receptor-mediated 
phagocytosis of F. novicida in D. discoideum and consequently entirely 
inhibit intracellular multiplication of bacteria when added 1 h before 
infection. When exanimating extracellular growth of bacteria in presence of 
inhibitor our results showed a slight difference in the extracellular 
multiplication among untreated cells and those treated with methylamine. 
Bacterial increase in 10-fold at 4 h p.i. and 100-fold at 5 h p.i. in the lack 
of inhibitor indicating that methylamine could potentially be toxic to F. 
novicida and has a weak influence on bacterial proliferation under favorable 
conditions. These results contrast with L. pneumophila infection whereas 
100 mM methylamine was not toxic and had no effect on extracellular 
multiplication of bacteria [52]. Regarding intracellular and extracellular 
multiplication of F. novicida when untreated with inhibitor we can observe 
typical decline in numbers 48 h after infection. In contrast, it is 
unexplainable why bacteria persisted longer in media with methylamine 
and continue to multiply 48 h p.i. 
Recent studies have shown the ability of methylamine to inhibit 
intracellular replication of L. pneumophila in amoeba H. vermioformis with 
a dose-dependent effect and complete inhibition of multiplication of 
bacteria when used 100 mM [52]. This inhibitor also greatly reduces entry 
and intracellular replication of L. pneumophila in A. castellanii in early 
stages of infection when added 1 h before infection in concentration of 100 
mM [51]. Considering L. pneumophila and F. tularensis similarities of life 
cycle in protozoa cells [36] we assumed methylamine would have similar 
inhibitory effect in Francisella entry and multiplication in amoeba such as 
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A. castellanii, as mentioned before. Our results confirmed that methylamine 
in concentration of 100 mM completely inhibit entry and intracellular 
replication of F. novicida within A. castellanii. Bacteria did not grow in 
presence of inhibitor with no detection in any time point. When untreated, 
bacteria grow intracellularly to greater than 105 CFU/mL with typical decline 
in numbers after 3 days of infection thereby pointing out the influence of 
methylamine on receptor-mediated phagocytosis. In contrast to D. 
discoideum, water-borne A. castellanii showed meaningful difference in 
extracellular multiplication of F. novicida when cells were treated with 
inhibitor. Although in first 24 h p.i. bacteria persisted longer and multiplied 
greater in medium with methylamine, there was a significant 10,000-fold 
and more increase in number of extracellular bacteria in the absence of 
inhibitor observed 24 hours after infection. The same number of bacterial 
CFU and decline in number after 3 days post infection was also presented 
in L. pneumophila extracellular multiplication without presence of 
methylamine [52]. These results affirm that inhibitor like methylamine 
could be toxic for F. novicida and therefore have long-term inhibitory effect 
on extracellular multiplication of bacteria under favorable conditions. 
One study pointed out that several levels of bacterial infection of the 
amoebae affect the total number of bacterial CFU when infected with 
virulent L. pneumophila [51]. To determine whether different doses of 
bacterial infection of D. discoideum and A. castellanii had an influence on 
bacterial kinetics of the assay, several MOIs were tested with F. novicida. 
When multiplied extracellularly bacteria showed almost no difference after 
treatment with inhibitor within different MOI but were influenced in the 
absence of methylamine with almost 10-fold increase with MOI 5 and 10 
and 100-fold increase with MOI. The intracellular replication of bacteria in 
untreated cells was differentiate among MOIs whereas for MOI 5 and 10 
bacteria started to multiply intracellularly at 4 h p.i. but proliferate from 
time point 0 with MOI 100. These results showed that a lower concentration 
of bacterial inoculum was considered as a lower concentration of 
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intracellular and extracellular bacteria in the absence of methylamine 
indicating that different levels of F. novicida infection of D. discoideum 
influenced a total number of bacterial CFU only when cells were not treated 
with inhibitor. 
There was also a variation in extracellular growth kinetics of F. 
novicida in A. castellanii when untreated with methylamine between 
different MOI with corresponding values 1016 CFU/mL for MOI 5,1018 
CFU/mL for MOI 10 and more than 1018 CFU/mL for MOI 100. When 
replicating intracellularly the number of bacteria differed among levels of 
infection whereas bacteria started proliferation at 24 h p.i. with MOI 5 and 
10 and at 4 h p.i. when infected with MOI 100. F. novicida reached up to 
106 CFU/mL when grown intracellularly at MOI 100, which correspond to 
results of intracellular replication of L. pneumophila in A. castellanii [51].   
A lower concentration of bacterial inoculum was also considered as a lower 
concentration of intracellular and extracellular bacteria showing that 
different MOIs of F. novicida also affect number of bacteria in A. castellanii 
in the absence of methylamine with no effect on treated cells.  
At last, the effect of multiplicity of infection (MOI) were examined in 
order to characterize the ideal model and provide productive infection, an 
optimal dose of infection for intracellular bacterial growth whereas bacterial 
proliferation does not cause a cell death.  
It has been indicated that concentrations of methylamine higher than 
250 mM in assay medium caused amoebae encystation within 24 h [52]. 
To determine whether methylamine in concentration of 100 mM affect the 
induction of cytopathogenicity in D. discoideum and A. castellanii cells 
infected with F. novicida LDH release assay was made. Our results showed 
that methylamine did not induce significant reduction of LDH release from 
infected D. discoideum. Infection dose of 5, at 2 and 4 h p.i. resulted in 
difference among the LDH levels of untreated and MA-treated cells (2 h p.i. 
P= 0.032, 4 h p.i. P= 0.007). In contrast, at 24, 48 and 72 h p.i. there was 
no notable difference between treated and untreated cells, which is 
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consistent with results of the extracellular growth. At infection dose 10, 
LDH release of untreated cells did not differ much from treated one with 
significant difference only 2 and 72 h (2 h p.i. P= 0.028, 72 h p.i. P= 0.025). 
When infected with dose of 100 cells per bacteria, LDH levels did not 
differentiate among treated and untreated cells with significance 2 and 24 
h post infection (2 h p.i. P=0.038, 24 h p.i. P= 0.010). The LDH releasee 
from F. novicida infected cells treated with MA was correlating in 
comparison with uninfected cells treated with MA for all doses of infection 
(MOI 5, 10 and 100) (unpublished data) which is in accordance to the 
intracellular growth of bacteria. 
The LDH levels in supernatant of infected and untreated A. castellanii 
cells did not differ from those treated with 100 mM methylamine. At MOI 
5, there was no notable difference between LDH release of treated and 
untreated cells in any time point. With MOI 10, LDH levels did not vary 
much with significant difference 24 and 72 h after infection (24 h p.i. P= 
0.022, 72 h p.i. P= 0.0505). When cells were infected with MOI of 100, the 
LDH release did not differentiate among untreated and MA treated cells with 
only one significance at 48 h after infection (48 h p.i. P= 0.041). This 
correspond to results from study that indicated that lower concentrations 
of methylamine were not toxic for amoebae or monocytes [52]. Increasing 
MOI from 5 to 100 comparatively follow enhancement trend in LDH levels 
in supernatant due to increase in extracellular and intracellular growth of 
bacteria.  
These results indicate that there is no significance difference of LDH 
levels in supernatant between treated and untreated cells. This 
demonstrate that methylamine does not affect inadequately the D. 
discoideum and A. castellanii cells and can be used as F. novicida entry 
inhibitor without being toxic for cells. These results also confirm statement 
from previous studies which claimed that methylamine in concentrations 
lover than 250 mM are not toxic to amoebae [52].  
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6. Conclusion 
F. tularensis has shown a major difference in lifestyle within 
macrophages and various protozoa cells. Within macrophages bacteria 
escape form FCV and continue replication in cytosol, while in A. castellanii 
F. tularensis replicate in intact vacuoles. Nevertheless, it has been shown 
that some amoebae, such as D. discoideum, occur in lifestyle more related 
to macrophages with similarities in phagosomal maturation and 
acidification and consequently escape and replication in cytosol. However, 
the molecular aspects of F. tularensis entry in both protozoa and 
mammalian cells are similar. Bacteria enters cells by receptor-mediated 
phagocytosis followed by extensive replication and lyses of host cell. Our 
results showed that if receptors are blocked with methylamine, inhibitor of 
phagocytosis, then F. novicida cannot be engulfed by cells and continue 
replication. These results were demonstrated in two different protozoa 
cells, a water-borne A. castellanii and social amoeba D. discoideum, with 
inhibitory effect of methylamine in both. We have also indicated that a 
lower concentration of bacterial inoculum (MOI) was represented as a lower 
concentration of intracellular and extracellular bacteria in the absence of 
methylamine. This implies that different levels of F. novicida infection of D. 
discoideum and A. castellanii influenced a total number of bacterial CFU 
only in the absence of inhibitor. To establish safety and non-toxicity of 
methylamine in concentration of 100 mM to amoebae cells LDH release test 
were made. The results imply that methylamine can be used as F. novicida 
entry inhibitor without being toxic for D. discoideum and A. castellanii due 
to no significance difference in LDH levels in supernatant among treated 
and untreated cells. Further studies will be important to identify the mode 
of action and molecular target of methylamine, since phagocytosis 
represent only way for bacterial entrance to cells. To conclude, our study 
has demonstrated influence of methylamine on receptor-mediated 
phagocytosis, crucial step for bacterial entry into cells, in protozoa with 
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different lifestyle in which similarities to macrophages could enable future 
analysis of metabolic inhibitors in higher evolutionary species.  
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